Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers
Authors:
- 1 January 2012
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 302 (1) , F173-F182
Abstract
The Nω-nitro-l-arginine methyl ester (l-NAME) model is widely employed to investigate the role of nitric oxide (NO) in renal injury. The present studies show that Sprague-Dawley rats from Harlan (H) and Charles River (CR) exhibit strikingly large differences in susceptibility to l-NAME nephropathy. After 4 wk of l-NAME (∼50 mg·kg−1·day−1in drinking water), H rats ( n = 13) exhibited the expected hypertension [average radiotelemetric systolic blood pressure (BP), 180 ± 3 mmHg], proteinuria (136 ± 17 mg/24 h), and glomerular injury (GI) (12 ± 2%). By contrast, CR rats developed less hypertension (142 ± 4), but surprisingly no proteinuria or GI, indicating a lack of glomerular hypertension. Additional studies showed that conscious H, but not CR, rats exhibit dose-dependent renal vasoconstriction after l-NAME. To further investigate these susceptibility differences, l-NAME was given 2 wk after 3/4 normotensive nephrectomy (NX) and comparably impaired renal autoregulation in CR-NX and H-NX rats. CR-NX rats, nevertheless, still failed to develop proteinuria and GI despite moderate hypertension (144 ± 2 mmHg, n = 29). By contrast, despite an 80–90% l-NAME dose reduction and lesser BP increases (169 ± 4 mmHg), H-NX rats ( n = 20) developed greater GI (26 ± 3%) compared with intact H rats. Linear regression analysis showed significant ( P < 0.01) differences in the slope of the relationship between BP and GI between H-NX (slope 0.56 ± 0.14; r = 0.69; P < 0.008) and CR-NX (slope 0.09 ± 0.06; r = 0.29; P = 0.12) rats. These data indicate that blunted BP responses to l-NAME in the CR rats are associated with BP-independent resistance to nephropathy, possibly mediated by a resistance to the renal (efferent arteriolar) vasoconstrictive effects of NO inhibition.Keywords
This publication has 40 references indexed in Scilit:
- Pressure-Induced Renal Injury in Angiotensin II Versus Norepinephrine-Induced Hypertensive RatsHypertension, 2009
- Protective Importance of the Myogenic Response in the Renal CirculationHypertension, 2009
- Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic MiceJournal of the American Society of Nephrology, 2006
- Differential effects of salt on renal hemodynamics and potential pressure transmission in stroke-prone and stroke-resistant spontaneously hypertensive ratsAmerican Journal of Physiology-Renal Physiology, 2005
- Substitution of chromosome 1 amelioratesl-NAME hypertension and renal disease in the fawn-hooded hypertensive ratAmerican Journal of Physiology-Renal Physiology, 2005
- Recommendations for Blood Pressure Measurement in AnimalsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Effects of calcium channel blockers on “dynamic” and “steady-state step” renal autoregulationAmerican Journal of Physiology-Renal Physiology, 2004
- Renoprotection by ACE Inhibition or Aldosterone Blockade Is Blood Pressure–DependentHypertension, 2003
- Interaction between nitric oxide and renal myogenic autoregulation in normotensive and hypertensive ratsCanadian Journal of Physiology and Pharmacology, 2001
- Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.Hypertension, 1992